Vasopeptidase inhibition: effective blood pressure control for vascular protection (Q34492839)

2 August 2017

1 reference

title

Vasopeptidase inhibition: effective blood pressure control for vascular protection (English)

1 reference

2 August 2017

2

Frank Ruschitzka

1 reference

2 August 2017

3

Thomas F Lüscher

1 reference

2 August 2017

Thomas Quaschning

1

1 reference

2 August 2017

1 February 2002

1 reference

Current Hypertension Reports

2 August 2017

1 reference

2 August 2017

4

1 reference

2 August 2017

1

1 reference

2 August 2017

78-84

1 reference

https://scigraph.springernature.com/pub.10.1007/s11906-002-0057-7

2 August 2017

0 references

cites work

Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin

1 reference

https://api.crossref.org/works/10.1007%2FS11906-002-0057-7

Generation by the phosphoramidon-sensitive peptidases, endopeptidase-24.11 and thermolysin, of endothelin-1 and c-terminal fragment from big endothelin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-002-0057-7

Vasopeptidase inhibition exhibits endothelial protection in salt-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-002-0057-7

Vasopeptidase Inhibition Prevents Endothelial Dysfunction of Resistance Arteries in Salt-Sensitive Hypertension in Comparison With Single ACE Inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-002-0057-7

Vasopeptidase inhibition has potent effects on blood pressure and resistance arteries in stroke-prone spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-002-0057-7

Antihypertensive and antihypertrophic effects of omapatrilat in SHR

21 January 2018

1 reference

12 December 2020

The Effect of the Angiotensin-Converting–Enzyme Inhibitor Zofenopril on Mortality and Morbidity after Anterior Myocardial Infarction

1 reference

12 December 2020

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

12 December 2020

Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial

1 reference

12 December 2020

Fosinopril reduces left ventricular mass in untreated hypertensive patients: a controlled trial

1 reference

12 December 2020

GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico

1 reference

12 December 2020

Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase by the orally active inhibitor mixanpril: a potential therapeutic approach in hypertension

1 reference

12 December 2020

Combined inhibition of neutral endopeptidase and angiotensin-converting enzyme by sampatrilat in essential hypertension

1 reference

12 December 2020

In vivo pharmacology of dual neutral endopeptidase/angiotensin-converting enzyme inhibitors

1 reference

12 December 2020

Vasopeptidase inhibition as a new concept in antihypertensive therapy.

1 reference

12 December 2020

Vasopeptidase inhibition and angio-oedema

1 reference

12 December 2020

Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions

1 reference

12 December 2020

Vasopeptidase inhibition attenuates the progression of renal injury in subtotal nephrectomized rats

1 reference

12 December 2020

Efficacy and safety of omapatrilat with hydrochlorothiazide for the treatment of hypertension in subjects nonresponsive to hydrochlorothiazide alone

1 reference

12 December 2020

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

12 December 2020

Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)

1 reference

12 December 2020

Design of orally active dual inhibitors of neutral endopeptidase and angiotensin-converting enzyme with long duration of action

1 reference

12 December 2020

Vasopeptidase inhibition

1 reference

12 December 2020

Vasopeptidase inhibition restores renovascular endothelial dysfunction in salt-induced hypertension

1 reference

12 December 2020

Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones

1 reference

12 December 2020

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

12 December 2020

Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme BMS-182657 in experimental hypertension and heart failure.

1 reference

12 December 2020

Chronic vasopeptidase inhibition restores endothelin-converting enzyme activity and normalizes endothelin levels in salt-induced hypertension

1 reference

12 December 2020

Inhibition of both angiotensin-converting enzyme and neutral endopeptidase by S21402 (RB105) in rats with experimental myocardial infarction

1 reference

12 December 2020

Mercaptoacyl dipeptides as orally active dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase

1 reference

12 December 2020

Chronic inhibition of endopeptidase 24.11 in essential hypertension: evidence for enhanced atrial natriuretic peptide and angiotensin II

1 reference

12 December 2020

Vasodilator Effects of Endothelin-Converting Enzyme Inhibition and Endothelin ET A Receptor Blockade in Chronic Heart Failure Patients Treated With ACE Inhibitors

1 reference

12 December 2020

Endogenous natriuretic peptides participate in renal and humoral actions of acute vasopeptidase inhibition in experimental mild heart failure

1 reference

12 December 2020

Kinins in the cardiovascular system

1 reference

12 December 2020

ACE inhibitors promote nitric oxide accumulation to modulate myocardial oxygen consumption

1 reference

12 December 2020

Dual inhibition of neutral endopeptidase and angiotensin-converting enzyme in rats with hypertension and diabetes mellitus

1 reference

12 December 2020

Vasopeptidase inhibitors--concepts and evidence

1 reference

12 December 2020

Effects of omapatrilat in low, normal, and high renin experimental hypertension

1 reference

12 December 2020

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

12 December 2020

10.1007/S11906-002-0057-7

Identifiers

DOI

1 reference

PubMed ID

11790296

Dimensions Publication ID

2 August 2017

0 references

1 reference

PubMed ID

11790296